Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma

Sara Cartwright, Abbey Fingeret

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE OF REVIEW: The purpose of this review is to describe the contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma with an emphasis on the clinical features. RECENT FINDINGS: Tall cell variant of papillary thyroid carcinoma is the most common aggressive subtype. Within the last few years, the diagnostic criteria for this entity have evolved. Studies have elucidated a better understanding of the clinical implications and pathophysiology of this variant. In this review, the studies presented reflect cumulative and aggregated data from metaanalyses, systematic reviews, and large database investigations utilizing the current diagnostic criteria. SUMMARY: Overall, tall cell variant of papillary thyroid carcinoma represents an aggressive subtype of well-differentiated thyroid carcinoma with more prevalent high-risk features and a poorer clinical outcome.

Original languageEnglish (US)
Pages (from-to)351-357
Number of pages7
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Volume27
Issue number5
DOIs
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma'. Together they form a unique fingerprint.

Cite this